Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enamine Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114276286A reveals a novel one-pot synthesis of N,N-disubstituted-alpha,beta-unsaturated enamines using DMSO and base, offering significant cost reduction in API manufacturing.
Novel iodine-catalyzed oxidative sulfonylation method for high-purity pharmaceutical intermediates with reduced costs and scalable production capabilities.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.